Shares of GlucoTrack, Inc. (NASDAQ:GCTK – Free Report) are scheduled to reverse split before the market opens on Monday, May 20th. The 1-5 reverse split was announced on Monday, May 20th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, May 20th.
GlucoTrack Trading Up 2.0 %
NASDAQ GCTK opened at $0.50 on Friday. GlucoTrack has a 52 week low of $0.13 and a 52 week high of $0.99. The company has a debt-to-equity ratio of 0.06, a quick ratio of 3.22 and a current ratio of 3.22. The stock’s 50 day moving average price is $0.47 and its two-hundred day moving average price is $0.32. The stock has a market capitalization of $13.38 million, a price-to-earnings ratio of -1.22 and a beta of 0.10.
GlucoTrack (NASDAQ:GCTK – Get Free Report) last posted its quarterly earnings data on Thursday, March 28th. The company reported ($0.10) EPS for the quarter.
Insider Activity
About GlucoTrack
GlucoTrack, Inc, a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.
See Also
- Five stocks we like better than GlucoTrack
- CD Calculator: Certificate of Deposit Calculator
- Take-Two Interactive Software Offers 2nd Chance for Investors
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Analysts Still Want Double-Digit Upside Out of Applied Materials
Receive News & Ratings for GlucoTrack Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlucoTrack and related companies with MarketBeat.com's FREE daily email newsletter.